Introduction
Testosterone replacement therapy (TRT) and bioidentical hormone replacement therapy (BHRT) for men represent one of the most rapidly evolving areas of integrative and functional medicine. Once confined to the treatment of classical hypogonadism, TRT is now widely used to address the broader spectrum of age-related testosterone decline, symptomatic androgen deficiency, and optimization of male hormonal health. This article examines the evidence base, delivery methods, clinical protocols, monitoring parameters, and optimization strategies for TRT and BHRT in men.
Defining the Candidates: Who Benefits from TRT?
TRT is appropriate when two conditions are met: biochemically confirmed testosterone deficiency and symptomatic burden attributable to that deficiency. Candidates typically present with:
- Total testosterone consistently below 300 ng/dL (or free testosterone below the lower reference range)
- Symptoms including fatigue, reduced libido, erectile dysfunction, loss of muscle mass, depression, cognitive decline, or reduced bone density
- Failure of lifestyle, nutritional, and botanical interventions to restore adequate testosterone levels
Men with secondary hypogonadism (low LH/FSH with low testosterone) may be candidates for alternative approaches — including clomiphene citrate or enclomiphene — that stimulate endogenous production rather than replacing it exogenously, particularly in men who wish to preserve fertility.
Bioidentical vs. Synthetic Hormones
Bioidentical hormones are chemically identical to the hormones produced by the human body. In the context of male TRT, bioidentical testosterone (derived from plant sterols and compounded or manufactured to match endogenous testosterone) is the standard of care in both conventional and integrative medicine. The distinction between "bioidentical" and "synthetic" is more clinically relevant in female hormone therapy; for men, all commonly used testosterone preparations — including FDA-approved products — are structurally identical to endogenous testosterone.
Delivery Methods
Intramuscular & Subcutaneous Injections
Testosterone cypionate and testosterone enanthate are the most commonly prescribed injectable forms. Administered weekly or biweekly, injections produce supraphysiologic peaks followed by troughs, which some men find symptomatic. More frequent dosing (e.g., twice weekly or subcutaneous microdosing) produces more stable serum levels and is increasingly preferred in integrative practice. Testosterone propionate has a shorter half-life and requires more frequent dosing.
Transdermal Gels & Creams
Topical testosterone gels (AndroGel, Testim) and compounded creams provide daily application with relatively stable serum levels. Advantages include ease of use and avoidance of injection-related discomfort. Disadvantages include transfer risk to partners and children, variable absorption, and lower peak levels compared to injections. Scrotal application of compounded testosterone cream significantly increases DHT conversion due to high 5-alpha reductase activity in scrotal skin — a consideration in men with DHT-sensitive conditions.
Subcutaneous Pellets
Testosterone pellets (Testopel) are implanted subcutaneously every 3–6 months, providing sustained release with stable serum levels. Advantages include convenience and consistent delivery. Disadvantages include the minor surgical procedure required for insertion, inability to adjust dose once implanted, and variable absorption rates between individuals.
Oral & Buccal Preparations
Testosterone undecanoate (Jatenzo, Tlando) is an oral formulation absorbed via the lymphatic system, bypassing first-pass hepatic metabolism. Buccal testosterone (Striant) is applied to the gum twice daily. These options are less commonly used in integrative practice but provide alternatives for men who cannot use injections or topicals.
Nasal Gel
Natesto is a nasal testosterone gel applied three times daily. It produces physiologic testosterone levels with minimal suppression of LH/FSH, making it a consideration for men who wish to preserve fertility while on TRT.
Clinical Protocols
Initiating TRT
Before initiating TRT, a comprehensive baseline evaluation should include:
- Total and free testosterone (morning, fasted, two separate measurements)
- LH, FSH, prolactin (to characterize hypogonadism type)
- Estradiol (sensitive assay)
- SHBG, CBC, comprehensive metabolic panel
- PSA (prostate-specific antigen) and digital rectal exam in men over 40
- Hematocrit and hemoglobin
- Lipid panel
- Sleep study if obstructive sleep apnea is suspected
Starting Doses
Typical starting doses vary by delivery method:
- Testosterone cypionate/enanthate: 100–200 mg/week IM or SQ (often split into twice-weekly doses)
- Transdermal gel: 50–100 mg/day
- Pellets: 150–450 mg per insertion (dose individualized by weight and baseline levels)
- Oral undecanoate: 158–316 mg twice daily with meals
Monitoring
Follow-up labs at 6–12 weeks after initiation, then every 6–12 months once stable:
- Total and free testosterone (trough for injections; mid-cycle for pellets)
- Estradiol — manage if above 40–50 pg/mL with symptoms
- Hematocrit — hold or reduce dose if above 54%
- PSA — annual monitoring; significant rise warrants urological evaluation
- Lipid panel and metabolic markers
Managing Estrogen on TRT
Exogenous testosterone provides additional aromatase substrate, often elevating estradiol. Estrogen management is one of the most nuanced aspects of TRT optimization:
- Aromatase inhibitors (AIs): Anastrozole (0.25–1 mg/week) or exemestane may be used when estradiol is elevated with symptoms (gynecomastia, water retention, mood changes). Over-suppression of estradiol causes joint pain, low libido, and cardiovascular risk — the goal is optimization, not elimination.
- Natural aromatase support: Zinc, DIM, calcium D-glucarate, and body composition improvement can reduce aromatization without pharmaceutical AIs in mild cases.
Preserving Fertility & Testicular Function
Exogenous testosterone suppresses LH and FSH via negative feedback, leading to testicular atrophy and impaired spermatogenesis. Men who wish to preserve fertility or testicular volume have several options:
- Human chorionic gonadotropin (hCG): Mimics LH, stimulating Leydig cell testosterone production and maintaining testicular size and function. Typically dosed at 500–1,000 IU two to three times weekly alongside TRT.
- Clomiphene citrate / enclomiphene: SERMs that block estrogen feedback at the hypothalamus, increasing GnRH, LH, and FSH — stimulating endogenous testosterone production without suppressing the HPG axis. Preferred for men with secondary hypogonadism who wish to preserve fertility.
Optimization Beyond Testosterone
Comprehensive male hormonal optimization extends beyond testosterone alone:
- DHEA: Precursor to testosterone and estrogen; supplementation (25–50 mg/day) may support hormonal balance, particularly in older men with low DHEA-S
- Pregnenolone: Master precursor hormone; supports neurological function and hormonal synthesis
- Thyroid optimization: Hypothyroidism suppresses SHBG and alters testosterone metabolism; thyroid function must be optimized concurrently
- Growth hormone / IGF-1: GH declines with age and interacts with testosterone in body composition and metabolic regulation; peptide secretagogues (ipamorelin, CJC-1295) are increasingly used in optimization protocols
Risks, Contraindications & Considerations
- Erythrocytosis: TRT stimulates red blood cell production; hematocrit above 54% increases thrombotic risk and requires dose reduction or therapeutic phlebotomy
- Prostate health: TRT does not cause prostate cancer but may stimulate growth of existing disease; PSA monitoring and urological evaluation are essential
- Cardiovascular risk: Evidence is mixed; TRT appears cardioprotective in hypogonadal men but may increase risk in those with pre-existing cardiovascular disease; individualized risk assessment is required
- Sleep apnea: TRT can worsen obstructive sleep apnea; screening and treatment of OSA before or concurrent with TRT initiation is recommended
- Absolute contraindications: Active prostate or breast cancer, untreated severe sleep apnea, hematocrit above 54%, desire for fertility without concurrent fertility preservation strategy
Conclusion
TRT and BHRT for men, when properly indicated, monitored, and optimized, represent powerful tools for restoring hormonal health, improving quality of life, and supporting long-term metabolic and cardiovascular function. The integrative approach — combining lifestyle foundations, nutritional support, and targeted hormonal therapy — produces superior outcomes to TRT in isolation. Individualization, comprehensive monitoring, and attention to the full hormonal ecosystem are the hallmarks of optimal male hormone therapy.
0 comments